124 related articles for article (PubMed ID: 38291705)
21. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
22. Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery.
Wei W; Sun J; Guo XY; Chen X; Wang R; Qiu C; Zhang HT; Pang WH; Wang JC; Zhang Q
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14839-14854. PubMed ID: 32182035
[TBL] [Abstract][Full Text] [Related]
23. Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo.
Jyotsana N; Sharma A; Chaturvedi A; Budida R; Scherr M; Kuchenbauer F; Lindner R; Noyan F; Sühs KW; Stangel M; Grote-Koska D; Brand K; Vornlocher HP; Eder M; Thol F; Ganser A; Humphries RK; Ramsay E; Cullis P; Heuser M
Ann Hematol; 2019 Aug; 98(8):1905-1918. PubMed ID: 31104089
[TBL] [Abstract][Full Text] [Related]
24. Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.
Yang Z; Duan J; Wang J; Liu Q; Shang R; Yang X; Lu P; Xia C; Wang L; Dou K
Int J Nanomedicine; 2018; 13():1851-1865. PubMed ID: 29618926
[TBL] [Abstract][Full Text] [Related]
25. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
[TBL] [Abstract][Full Text] [Related]
26. PEI fluorination reduces toxicity and promotes liver-targeted siRNA delivery.
Xue L; Yan Y; Kos P; Chen X; Siegwart DJ
Drug Deliv Transl Res; 2021 Feb; 11(1):255-260. PubMed ID: 32506259
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.
Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A
J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504
[TBL] [Abstract][Full Text] [Related]
28. siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.
Abbasi M; Aliabadi HM; Moase EH; Lavasanifar A; Kaur K; Lai R; Doillon C; Uludağ H
Pharm Res; 2011 Oct; 28(10):2516-29. PubMed ID: 21638135
[TBL] [Abstract][Full Text] [Related]
29. Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging.
Merkel OM; Librizzi D; Pfestroff A; Schurrat T; Buyens K; Sanders NN; De Smedt SC; Béhé M; Kissel T
J Control Release; 2009 Sep; 138(2):148-59. PubMed ID: 19463870
[TBL] [Abstract][Full Text] [Related]
30. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
31. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
[TBL] [Abstract][Full Text] [Related]
32. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
Lu ZX; Liu LT; Qi XR
Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
[TBL] [Abstract][Full Text] [Related]
33. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
Höbel S; Aigner A
Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional drug carrier based on PEI derivatives loaded with small interfering RNA for therapy of liver cancer.
Zhao Y; Lee RJ; Liu L; Dong S; Zhang J; Zhang Y; Yao Y; Lu J; Meng Q; Xie J; Teng L
Int J Pharm; 2019 Jun; 564():214-224. PubMed ID: 31004717
[TBL] [Abstract][Full Text] [Related]
35. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A
J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
Mohseni M; Kucharski C; K C RB; Nasrullah M; Jiang X; Uludağ H; Brandwein J
PLoS One; 2021; 16(6):e0251719. PubMed ID: 34157051
[TBL] [Abstract][Full Text] [Related]
37. Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system.
Nimesh S; Chandra R
Eur J Pharm Biopharm; 2009 Sep; 73(1):43-9. PubMed ID: 19362592
[TBL] [Abstract][Full Text] [Related]
38. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
39. Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.
Xie Y; Kim NH; Nadithe V; Schalk D; Thakur A; Kılıç A; Lum LG; Bassett DJP; Merkel OM
J Control Release; 2016 May; 229():120-129. PubMed ID: 27001893
[TBL] [Abstract][Full Text] [Related]
40. Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.
Aigner A
J Biomed Biotechnol; 2006; 2006(4):71659. PubMed ID: 17057369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
